Stereotaxis' EMAGIN Catheter: A New Era in Endovascular Procedures
Generated by AI AgentMarcus Lee
Tuesday, Mar 4, 2025 7:45 am ET1min read
Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, has submitted its EMAGIN™ 5F catheter for regulatory clearance, marking a significant milestone in the expansion of Robotic Magnetic Navigation into the broader endovascular field. The EMAGIN brand, short for Endovascular Magnetic Intervention, encompasses a comprehensive portfolio of robotic catheters and wires, with the EMAGIN 5F being the first in this family of robotically navigated endovascular devices.
The EMAGIN 5F catheter is a 5-French diameter catheter guide designed to navigate tortuous venous and arterial vasculature efficiently and safely. Utilizing precise magnetic fields for robotic navigation directly from the distal tip, the catheter enables efficient and safe navigation to otherwise difficult-to-reach vascular anatomy. This expands the established benefits of Robotic Magnetic Navigation into multiple new clinical applications, including minimally-invasive procedures used to treat stroke, cancer, and cardiovascular disease.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet